Science & Tech · Science & Environment · 18 hrs ago
Delft company Delmic expands automation for electron microscopes
Delmic is a company spun off from Delft University of Technology in the Netherlands.
It makes systems that automate electron microscopes, which researchers use to develop chips, medicines and quantum computers.
The company says microscope operation in labs can still be slow and cumbersome.
Nearly 250 Delmic systems are now in laboratories worldwide, including labs at Harvard, MIT and Google.
Delmic reported revenue of more than €10 million in 2025.
It is working on a new funding round so it can also focus on industrial customers.
The company aims to exceed €100 million in revenue by 2032.
Delft-based Delmic is automating electron microscopes used in research on chips, medicines and quantum computers.
Nearly 250 Delmic systems are operating in leading laboratories worldwide.
The company reported revenue of more than €10 million in 2025.
Delmic is raising funds to expand into industrial customers.
It aims to exceed €100 million in revenue by 2032.
- Who
- Delmic, a spin-off from Delft University of Technology.
- What
- It automates electron microscopes and is raising funds to target industrial customers.
- When
- The article was published on 11 October 2026; the company reported its 2025 revenue and aims to exceed €100 million in revenue by 2032.
- Where
- Delft, the Netherlands, and laboratories worldwide.
- Why
- To make electron microscopes more productive and expand into industrial customers.
This story does not have two clearly opposing sides.
It is almost impossible to describe how clumsily things sometimes go in laboratories.
Delmic's revenue was more than €10 million.
FD reported that Delmic was raising funds to focus on industrial customers.
Delmic aims to exceed €100 million in revenue.
- Company
- Delmic
- Origin
- Spin-off from Delft University of Technology
- Systems
- Nearly 250 operating in leading laboratories worldwide
- Revenue
- More than €10 million in 2025
- Revenue ambition
- More than €100 million by 2032







